The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with bacillus Calmette-Guérin–unresponsive high-risk non–muscle-invasive bladder cancer who demonstrated nonresponse to pembrolizumab in KEYNOTE-057: A post hoc analysis.
 
Roger Li
Stock and Other Ownership Interests - Beam Therapeutics; CRISPR therapeutics; Editas Medicine; Guardant Health; Intellia Therapeutics; Lilly
Consulting or Advisory Role - Bristol-Myers Squibb; CG Oncology; Lucence Diagnostics; Merck; Thericon
Research Funding - CG Oncology; Predicine; Valar Labs
Travel, Accommodations, Expenses - CG Oncology; Predicine
Other Relationship - Predicine
 
Joshua Linscott
No Relationships to Disclose
 
Girish S. Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; Knight Pharmaceuticals; Photocure; Tersera
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Pfizer; Theralase; Verity Pharmaceuticals
Research Funding - Johnson & Johnson/Janssen (Inst)
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Catalym; Genenta Science; Gilead Sciences; Incyte; Janssen; Merck Sharp & Dohme; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme
 
Mathieu Roumiguié
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Oncodiag; Pfizer
Expert Testimony - Ferring; Ipsen; Janssen
 
Eric A. Singer
Consulting or Advisory Role - Aura Biosciences; Johnson & Johnson/Janssen; Merck; Vyriad
Research Funding - Astellas Medivation
 
Edward M. Uchio
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; CG Oncology; Dendreon; Janssen Oncology; Merck; Pfizer; Seagen
(OPTIONAL) Uncompensated Relationships - Astellas Pharma; AstraZeneca; Bayer; Genomic Health; Janssen Oncology; Lantheus Medical Imaging; Merck; Myriad Genetics; Pfizer
 
Joost L Boormans
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; ISMAR Health Care; Janssen; Merck KGaA; MSD
Research Funding - Janssen; Merck KGaA; Vitroscan
 
Aiwen Xing
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Margot Van den Sigtenhorst
Stock and Other Ownership Interests - Merck
 
Ekta Kapadia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Ashish M. Kamat
Honoraria - AstraZeneca (I); Tesaro (I)
Consulting or Advisory Role - Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Cystotech; Eisai; EnGeneIC; FerGene; Imagin Medical; Imvax; Incyte; Janssen; Medac; Merck; Nonagen Bioscience; Pfizer; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; TMC Innovation; Urogen pharma; US Biotest
Research Funding - Adolor; Bristol-Myers Squibb; FKD Therapies; Heat Biologics; Janssen/Taris; Merck; NIH; Patient-Centered Outcomes Research Institute (PCORI); Photocure; Seagen; SWOG; Taris BioMedical; The Leo & Anne Albert Institute for Bladder Cancer Care and Research (AIBCCR)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; International Bladder Cancer Group (IBCG); International Bladder Cancer Network; Journal of Urology; UroToday